​
​

ARCA biopharma (ABIO) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

ARCA biopharma Revenue Highlights

00

ARCA biopharma Revenue by Period

ARCA biopharma Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31--100.00%
2008-12-31$15.25M-67.45%
2007-12-31$46.86M1105.27%
2006-12-31$3.89M613.39%
2005-12-31$545.00K179.49%
2004-12-31$195.00K-91.48%
2003-12-31$2.29M-91.34%
2002-12-31$26.43M7.49%
2001-12-31$24.59M57.59%
2000-12-31$15.60M143.81%
1999-12-31$6.40M-33.33%
1998-12-31$9.60M54.84%
1997-12-31$6.20M1450.00%
1996-12-31$400.00K-

ARCA biopharma generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

ARCA biopharma Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$176.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31--100.00%
2008-12-31$63.00K-
2008-09-30$63.00K-99.86%
2008-06-30$45.06M71426.98%
2008-03-31$63.00K-
2007-12-31$63.00K-

ARCA biopharma generated - in revenue during Q1 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

ARCA biopharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics$101.21M$33.43M
SPROSpero Therapeutics$96.73M$13.47M
ADAGAdagene$18.11M$833.34K
MGTADianthus Therapeutics$314.00K$72.00K
RZLTRezolute--
FBRXForte Biosciences--
ANTXAN2 Therapeutics--
AVTEAerovate Therapeutics--
ABIOARCA biopharma--
NXTCNextCure--
TILInstil Bio--
RNXTRenovoRx--
NLTXNeurogene--
TPSTTempest Therapeutics--
ACRVAcrivon Therapeutics--
INDPIndaptus Therapeutics--
SIOXSio Gene Therapies--
QNRXQuoin Pharmaceuticals--
KTTAPasithea Therapeutics--

ABIO Revenue FAQ

What is ARCA biopharma’s yearly revenue?

ARCA biopharma's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. ABIO's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is ARCA biopharma’s quarterly revenue?

ARCA biopharma's quarterly revenue for Q1 2024 was $0, a 100.00% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $0, a -100.00% decrease from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). ABIO's quarterly revenue for Q3 2023 was $176K, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

What is ARCA biopharma’s revenue growth rate?

ARCA biopharma's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.